References
- Institute of Medicine Committee on Advancing Pain Research, Care, and, Education. The National Academies Collection: reports funded by National Institutes of Health. Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Washington, DC: National Academies Press, 2011
- Harstall C, Ospina M. How prevalent is chronic pain? Pain clinical updates. Vol 6. Seattle, WA: International Association for the Study of Pain, 2003. p 1-4
- Smith BH, Elliott AM, Chambers WA, et al. The impact of chronic pain in the community. Famil Pract 2001;18:292-9
- Gureje O, Von Korff M, Simon GE, et al. Persistent pain and well-being: a World Health Organization Study in Primary Care. JAMA 1998;280:147-51
- Argoff CE, Silvershein DI. A comparison of long- and short-acting opioids for the treatment of chronic noncancer pain: tailoring therapy to meet patient needs. Mayo Clin Proc 2009;84:602-12
- Kuehn BM. Opioid prescriptions soar: increase in legitimate use as well as abuse. JAMA 2007;297:249-51
- Express Scripts. A Nation in pain: focusing on U.S. opioid trends for treatment of short-term and longer-term pain. 2014
- Rice J, Samuelson T, Birnbaum H, et al. Characteristics and use patterns of chronic hydrocodone users. J Pain 2012;13:S80
- Danielson E. Health research data for the real world: The MarketScan® Databases. Truven Health Analytics, 2014
- Charlson ME, Charlson RE, Peterson JC, et al. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol 2008;61:1234-40
- Graubard BI, Korn EL. Predictive margins with survey data. Biometrics 1999;55:652-9
- Bates DW, Saria S, Ohno-Machado L, et al. Big data in health care: using analytics to identify and manage high-risk and high-cost patients. Health Affairs 2014;33:1123-31
- Cicero TJ, Wong G, Tian Y, et al. Co-morbidity and utilization of medical services by pain patients receiving opioid medications: data from an insurance claims database. Pain 2009;144:20-7
- Leider HL, Dhaliwal J, Davis EJ, et al. Healthcare costs and nonadherence among chronic opioid users. Am J Manage Care 2011;17:32-40
- Gaskin DJ, Richard P. The economic costs of pain in the United States. J Pain Off J Am Pain Soc 2012;13:715-24
- Fitch K, Pyenson BS, Iwasaki K. Medical claim cost impact of improved diabetes control for medicare and commercially insured patients with type 2 diabetes. JMCP Oct 2013;19:609-20, 620a-620d
- IMS Institute for Healthcare Informatics. Essential health benefit packages explained: understanding high-cost patients. www.theimsinstitute.org. Accessed 2014
- Bron M, Guerin A, Latremouille-Viau D, et al. Distribution and drivers of costs in type 2 diabetes mellitus treated with oral hypoglycemic agents: a retrospective claims data analysis. J Med Econ 2014;17:646-57